These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 318952

  • 1. Spironolactone and hydrochlorothiazide in normal-renin and low-renin essential hypertension.
    Ferguson RK, Turek DM, Rovner DR.
    Clin Pharmacol Ther; 1977 Jan; 21(1):62-9. PubMed ID: 318952
    [Abstract] [Full Text] [Related]

  • 2. Diuretic therapies in low renin and normal renin essential hypertension.
    Brooks CS, Johnson CA, Kotchen JM, Kotchen TA.
    Clin Pharmacol Ther; 1977 Jul; 22(1):14-20. PubMed ID: 326459
    [Abstract] [Full Text] [Related]

  • 3. Hydrochlorothiazide and spironolactone in hypertension.
    Schrijver G, Weinberger MH.
    Clin Pharmacol Ther; 1979 Jan; 25(1):33-42. PubMed ID: 363334
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A comparison between spironolactone and hydrochlorothiazide with and without alpha-methyldopa in the treatment of hypertension.
    Walter NM, Suthers MB, Friedman A, Johnston CI.
    Med J Aust; 1978 May 06; 1(9):509-12. PubMed ID: 353458
    [Abstract] [Full Text] [Related]

  • 6. [Spironolactone and thiabutazide in the treatment of essential hypertension (author's transl)].
    Klump F, Braun B, Klaus D, Lemke R, Zehner J, Zöfel P.
    Dtsch Med Wochenschr; 1975 Mar 21; 100(12):577-84. PubMed ID: 1168122
    [Abstract] [Full Text] [Related]

  • 7. Similar effects of hydrochlorothiazide and spironolactone on plasma renin activity in essential hypertension.
    Acchiardo S, Dustan HP, Tarazi RC.
    Cleve Clin Q; 1972 Mar 21; 39(4):153-62. PubMed ID: 4660197
    [No Abstract] [Full Text] [Related]

  • 8. Double-blind comparison of triamterene plus hydrochlorothiazide and spironolactone plus hydrochlorothiazide in the treatment of hypertension.
    Cocke TB, Fisch S, Gilmore HR, Okun R, Tamagna IG, Wipplinger K.
    J Clin Pharmacol; 1977 Mar 21; 17(5-6):334-8. PubMed ID: 323298
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of renin classification for diuretic treatment of black hypertensive patients.
    Holland OB, Gomez-Sanchez C, Fairchild C, Kaplan NM.
    Arch Intern Med; 1979 Dec 21; 139(12):1365-70. PubMed ID: 518220
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
    Kreeft JH, Larochelle P, Ogilvie RI.
    Can Med Assoc J; 1983 Jan 01; 128(1):31-4. PubMed ID: 6336600
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The patient with mild to moderate essential hypertension: peripheral renin activity and a comparative drug study.
    Merkle GW, Bader PI, Creason PL, Townsend DW, Conn PS, Lakes MK, Campbell NM.
    J Indiana State Med Assoc; 1981 Jul 01; 74(7):444-9. PubMed ID: 7024422
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.